Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A Canadian class action lawsuit aims to hold numerous drug companies accountable for allegedly selling heartburn medication Zantac that was contaminated with a carcinogen.
The Zantac class action lawsuit was filed by M. Royer, a Quebec resident who reportedly purchased Zantac that was contaminated.
He aims to represent a Class of all Canadian residents who purchased the allegedly contaminated drug, and a subclass of all Quebec residents who did the same.
The Canada Zantac class action lawsuit names multiple drug companies as defendants, including Sanofi Consumer Health, GlaxoSmithKline, Sandoz Canada, Pharmascience, Apotex, Pro Doc, Sanis Health, and Sivem Pharmacueticals. The companies are all allegedly makers of contaminated Zantac, also sold in its generic form ranitidine.
According to Royer, Zantac is the best-selling drug in history due to the drug companies’ marketing. Allegedly, Zantac’s popularity in Canada was only possible because the drug companies misrepresented it to consumers as being a safe way to treat heartburn and gained profits from this deception.
The companies reportedly sell the drug throughout Canada without disclosing that it may contain N-Nitrosodimethylamine (NDMA), a possible carcinogen. Royer stresses that the World Health Organization has deemed NDMA “clearly carcinogenic,” and Health Canada calls it a “probable human carcinogen.”
The carcinogen can appear in some foods and can be formed in the stomach during digestion of foods that contain alkylamine, a naturally occurring substance. However, Royer says that NDMA may be present in high levels in Zantac drugs and its presence may be dangerous to consumers. Allegedly, reports have discovered levels of NDMA in Zantac that may be as much as 26,000 times greater than safe levels.
Royer stresses that this could put many Canadian consumers at risk because many take Zantac over long periods of time and this extended use may increase the amount of NDMA that consumers could ingest. The plaintiff supports this by saying that when Zantac was tested “in conditions simulating the human stomach,” the amount of NMDA discovered was around 3,171 times more than what can be safely ingested on a daily basis.
The Canada Zantac class action lawsuit says that the drug companies knew or should have known that the drug was contaminated before they put it on the market.
Allegedly, multiple studies were published during the time that the companies manufactured and distributed the drug that showed the contamination. However, the companies reportedly failed to warn consumers despite their knowledge.
Similar concerns over contamination have affected U.S. consumers, as well. The drug has been subjected to some recalls as a result of the potential contamination.
Have you used Zantac or ranitidine? Let us know in the comment section below.
Royer is represented by Andrea Grass of the Consumer Law Group Inc.
The Canada Zantac NDMA Contamination Class Action Lawsuit is M. Royer v. Sanofi Consumer Health Inc., et al., Case No. 500-06-001023-197, in the Canada Superior Court in the Providence of Quebec for the District of Montreal.
Read More Lawsuit & Settlement News:
Facebook Data Breach Class Action Gets Certification for Injunctive Relief
Catholic Church Sex Offenders Should Not Face Old Allegations, Says Suit by Rockville Centre Diocese
Access Asia Tours Class Action Filed After Cancelled Hong Kong Tour
Two Priests from New Jersey Catholic Churches Face Criminal Charges from AG’s Task Force
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
89 thoughts onCanada Zantac Class Action Filed Over Unsafe Levels of Carcinogen
I was perscribed zantac and ranatidine also for many years, and developed breast cancer, now I have major problems with my stomach, eliminating and diarhia and constipation issues with a bloating gut. In and out of doctors office twice a month, ongoing. I can not work now and have not been able to for over 4 years now because of my stomach and eliminating problems.
I took Ranitidine after my Kidney transplant for GERD. It was not as effective as the Pantalock I had been taking, but was easier on the new kidney.
Several years later I developed bladder cancer and had it the prostrate and lymph nodes all removed.
Now i wear a Urostomy bag to pee into glued to my stomach
And sex has no ejaculation now.
I took a perscription for ranitine for years and was very sick ,in and out of the hospital at least once to three times a month , for stomache problems . I would be sent home with another persription .
I took zantax for over a year in 2019- 2020. In 21 I was diagnosed with kidney cancer. There was a cancerous tumor in my right kidney. The entire kidney was removed June 10, 2021 in Montreal, Quebec; the falopian tube and ovary were removed as well. This operation was followed by two emergencies back to hospital. I developed blood clots on my lungs + a major infection. It was a hell-of-a year. The recovery was long and disabling. I’m not yet fully recovered. Still have pain at times.
I took Zantac over a number of years 1995 ….2020. Was in a high stress job and had acid reflux bad started with 75mg and eventually increased to 2 tabs then to the 150 tabs . Out of nowhere I was diagnosed with prostate cancer and had a prostatectomy in 2008. I lost the ability to be intimate with my wife and had to take needles to achieve and erection . Talk about a buzz kill . Depression and other issues turned up . I took a Zantac in 2019 which we had at our summer trailer without being aware of the danger.
I have taken ZanTac and was prescribed Ranatadine.